Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models
Combination effect of PectaSol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU-145 and LNCaP prostate cancer cell lines
PectaSol-C Modified Citrus Pectin Induces Apoptosis and Inhibition of Proliferation in Human and Mouse Androgen-Dependent and - Independent Prostate Cancer Cells
ProstaCaid Induces G2/M Cell Cycle Arrest and Apoptosis in Human and Mouse Androgen–Dependent and – Independent Prostate Cancer Cells
Activation of Human T-Helper/Inducer Cell, T-Cytotoxic Cell, B-Cell, and Natural Killer (NK)- Cells and induction of Natural Killer Cell Activity against K562 Chronic Myeloid Leukemia
Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study
Suppression of growth and invasive behavior of human prostate cancer cells by ProstaCaidTM: Mechanism of activity
ProstaCaidTM inhibits tumor growth in a xenograft model of human prostate cancer
Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model
Jiang Eliaz Sliva Synergistic MCP ProstaCaid BreastDefend Integr Cancer Ther 2012
Clinical Benefit in Patients with Advanced Solid Tumors Treated with Modified Citrus Pectin: A Prospective Pilot Study
Jiang BreastDefend Oncology Reports July 26 2012
Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells
Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells